PROBLEM OF COGNITIVE IMPAIRMENT IN CLINICAL PRACTICE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article describes the range of cognitive impairments that occur in clinical practice, their importance in the daily livings of patients, and associated recovery problems. The place of memantine in the treatment of cognitive disorders of varying severity and different etiologies is discussed. The possibilities of the use of original memantine and generic drugs are considered.

Full Text

Restricted Access

About the authors

S. V Prokopenko

SBEI HPE «Krasnoyarsk State Medical University n.a. Prof. V.F. Voyno-Yasenetsky» of RMH

MD, Prof., Head of the Department of Nervous Diseases with the Course of Medical Rehabilitation PGE Krasnoyarsk

E. Yu Mozheyko

SBEI HPE «Krasnoyarsk State Medical University n.a. Prof. V.F. Voyno-Yasenetsky» of RMH

Krasnoyarsk

T. D Koryagina

SBEI HPE «Krasnoyarsk State Medical University n.a. Prof. V.F. Voyno-Yasenetsky» of RMH

Krasnoyarsk

T. S Anay-ool

SBEI HPE «Krasnoyarsk State Medical University n.a. Prof. V.F. Voyno-Yasenetsky» of RMH

Krasnoyarsk

E. G Shanina

SBEI HPE «Krasnoyarsk State Medical University n.a. Prof. V.F. Voyno-Yasenetsky» of RMH

Krasnoyarsk

M. M Petrova

SBEI HPE «Krasnoyarsk State Medical University n.a. Prof. V.F. Voyno-Yasenetsky» of RMH

Krasnoyarsk

References

  1. Хомская Е.Д. Нейропсихология. 4-е изд. СПб., 2007. 496 с.
  2. Levitt T., Johnstone B. The assessment and rehabilitation of attention disorders. Ed. B. Johnstone, H.H. Stonnington. Rehabilitation of neuropsychological disorders. A practical guide for rehabilitation professionals. New York, London, 2009. 23-45.
  3. Lezak M.D., Howieson D.B., Loring D.W. Neuropsychological assessment. 4-th edition. New York, 2004. 1016 p.
  4. Barret A.M. Remediation of spatial neglect, apraxia and other cognitive disorders after stroke. Materials of 60th Annual Meeting of American Academy of Neurology. Education Program Syllabus. Chicago, April 12-19, 2008. 8AC006.17. 8AC006.27.
  5. Manly T., Mattingley J.B. Visuospatial and attentional disorders. Ed. by L.H. Goldstein, J.E McNeil. Clinical neuropsychology. A practical guide to assessment and management for clinicians. Ltd., England, 2004. P. 229-51.
  6. Доброхотова Т.А., Зайцев О.С. Психопатология черепно-мозговой травмы/ Под ред. А.Н. Коновалова, Л.Б. Лихтермана, А.А. Потапова. Клин. руководство по черепно-мозговой травме. М., 1998. C. 269-313.
  7. Корсакова Н.К., Московичюте Л.И. Клин. нейропсихология. М., 2003. 144 с.
  8. Skeel R.L., Edwards S. The assessment and rehabilitation of memory impairments. Ed. by B. Johnstone, H.H. Stonnington. Rehabilitation of neuropsychological disorders. A practical guide for rehabilitation professionals. New York, London, 2009. P. 47-73.
  9. Захаров В.В., Яхно Н.Н. Нарушения памяти. Справочное руководство для врачей. М., 2003. 160 с.
  10. Цветкова Л.С. Афазия и восстановительное обучение. М., 2001. 256 с.
  11. Poeck K., Huber W., Willmes K. Outcome of intensive language treatment in aphasia. Speech Hear Disord. 1989;54(3):471-79.
  12. Burdess P.W., Alderman N. Executive dysfunctions. Ed. by L.H Goldstein., J.E. McNeil. Clinical neuropsychology. A practical guide to assessment and management for clinicians. Ltd., England, 2004. P. 185-208.
  13. Григорьева В.Н., Ковязина М.С., Тхостов А.Ш. Когнитивная реабилитация больных с инсультом и черепно-мозговой травмой. Н. Новгород, 2012. 324 с.
  14. Cicerone K.D., Dahlberg C., Kalmar L., Langenbahn D.M., Malec J.F., Bergquist T.F., Felicetti T., Giacino J.T., Harley J.P., Harrington D.E., Herzog J., Kneipp S., Laatsch L., Morse P.A. Evidence-based cognitive rehabilitation: recommendations for clinical practice. Arch. Phys. Med. 2000;81(12):1596-615.
  15. Hanna-Paddy B., Heilman K.M., Foundas A.L. Cortical and subcortical contribution to ideomotor apraxia. Analysis of task demands and error types. Brain. 2001;124(12):2513-27.
  16. Goldenberg G., Daumuller M., Hagman S. Assessment and therapy of complex activities of daily living in apraxia. Neuropsychol. Rehabil. 2001;11:147-69.
  17. Bowen A., West C., Hesketh A., et al. Rehabilitation for Apraxia. Evidence for ShortTerm Improvements in Activities of Daily Living. Stroke. 2009;40(5):396-97.
  18. Способ восстановления когнитивных функций при цереброваскулярной патологии. Патент РФ № 2 586 312(13) C1 Опубликовано: 10.06.2016. Бюл. № 16.
  19. Kornhuber J., Wiltfang J. The role glutamate in dementia. J. Neural. Transm. 1998;53:277-87.
  20. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res. Rev. 1999;30:289-304.
  21. Kemp J.A., McKernan R.M. NMDA receptors as drug targets. Nature Neurosci. 2002;5:1039-42.
  22. Parsons C.G., Danysz W., Quack G. Memantine is a clinically well-tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of the preclinical data. Neuropharmacology. 1999;38:735-67.
  23. Дамулин И.В. Новая нейропротективная и терапевтическая стратегия при деменциях: антагонист NMDA-рецепторов Акатинол Мемантин. РМЖ. 2001;9(25):1178-82.
  24. Winblad B., Jones R., Wirth Y., Stöffler A.,Möbius H. Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials. Dement. Geriatr. Cogn. Disord. 2007;24(1):20-7.
  25. Orgogozo J.M., Rigaud A.S., Stöffler A., Möbius H.J., Forette F. Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia: A Randomized, Placebo-Controlled Trial (MMM 300). Stroke. 2002;33:1834-39.
  26. Wedlock G., Möbius H.J., Stöffler A. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM-500). Int. Clin. Psychopharmacol. 2002;17:297-305.
  27. Яхно Н.Н., Преображенская И.С., Захаров В.В., Мхитарян Э.Я. Эффективность Акатинола Мемантина у пациентов с недементными когнитивными расстройствами. Результаты многоцентрового клинического наблюдения. Неврол. журн. 2010;2:52-8.
  28. Gautheir S., Wirth Y., Mоbius H.J. Effects of Memantine in Behavioural Symptoms in Alzheimer's Disease Patients: An Analysis of the Neuropsychiatric Inventory (NPI) Data of Two Randomized, Controlled Studies. J. Geriatr. Psychiatry. 2005;20:1-6.
  29. Schmidt R., Ropele S., Ebenbaue B., et al. Memantine effects on brain volume, glucose metabolism and cognition in AD patients. Eur. J. Neurology. 2007;14(1);25-6.
  30. Li L., Sengupta A., Haque N., Grundke-Iqbal I., Iqbal K. Memantine inhibits and reverses the Alzheimer's type abnormal hyperphosphorylation of tau and associated neurodegeneration. FEBS Letters. 2004;566:261-69.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies